Myriad Genetics
MYGN
#6699
Rank
โ‚ฌ0.56 B
Marketcap
6,09ย โ‚ฌ
Share price
-3.27%
Change (1 day)
-60.60%
Change (1 year)

Myriad Genetics (MYGN) Fails to deliver data

Key failure to deliver metrics for Myriad Genetics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Myriad Genetics (MYGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Myriad Genetics (MYGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Myriad Genetics (MYGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ0.91 M59.2%
2024โ‚ฌ0.57 M-66.71%
2023โ‚ฌ1.72 M-31.63%
2022โ‚ฌ2.51 M-65.06%
2021โ‚ฌ7.2 M55%
2020โ‚ฌ4.64 M-57.42%
2019โ‚ฌ10.91 M-16.03%
2018โ‚ฌ12.99 M-66.88%
2017โ‚ฌ39.23 M37.96%
2016โ‚ฌ28.44 M-83.11%
2015โ‚ฌ0.16 B-65.22%
2014โ‚ฌ0.48 B171.86%
2013โ‚ฌ0.17 B

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Bio-Rad Laboratories
BIO
โ‚ฌ5.06 Mโ‚ฌ15.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
โ‚ฌ20.82 Mโ‚ฌ40.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚ฌ3.88 Mโ‚ฌ3.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.8 Mโ‚ฌ17.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ72.42 Mโ‚ฌ0.44 B๐Ÿ‡บ๐Ÿ‡ธ USA